SecBot SecBot
144 ·Filed Nov 2, 2026

ORKA

Oruka Therapeutics, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed14d 8h ago SEC0001950047-26-010585
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is part of a pre-arranged 10b5-1 plan and is small relative to market cap, so it does not signal a change in insider sentiment. Monitor for any acceleration of insider selling beyond the plan's disclosed schedule.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$99.55
T+0 close · Nov 2, 2026 · via day close
Latest settled
+9.99%
T+5 · $109.50 · next T+20 in 15d
Vs SPY
+10.58%
α at T+5
Latest observation
+6.65%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $99.55entry
  2. T+1 · 13d ago +1.87%α +0.22% · $101.41
  3. T+5 · 7d ago +9.99%α +10.58% · $109.50
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Lawrence Klein filed a Form 144 notice of intent to sell 25,000 shares of Oruka Therapeutics common stock, with an estimated aggregate market value of approximately $2.42 million based on the filing price. The sale is planned for November 2, 2026, and the shares were acquired through the exercise of stock options. Klein has a history of recent sales under a 10b5-1 plan, including 75,000 shares sold on September 1, 2026, and 25,000 shares sold on October 1, 2026, totaling over $9 million in recent dispositions.

Key Facts

  • Director Lawrence Otto Klein filed Form 144 to sell 25,000 shares of Oruka Therapeutics common stock.
  • Estimated aggregate market value of the proposed sale is $2,421,750.
  • Shares were acquired via exercise of stock options on November 2, 2026.
  • Klein has sold 100,000 shares in the prior two months under a 10b5-1 plan (75,000 on Sep 1, 2026 and 25,000 on Oct 1, 2026).
  • The 25,000 shares represent approximately 0.04% of the company's $6.4B market cap.
  • The filing is an advance notice of intent to sell, not a completed transaction.

Financial Impact

Proposed sale of 25,000 shares valued at ~$2.42M, representing ~0.04% of market cap.

dilution

Risk Factors

  • Form 144 is only an intent to sell; the actual sale may not occur.
  • Insider has sold over $9M in shares in the past two months under the same 10b5-1 plan, which could indicate ongoing portfolio diversification rather than a negative view.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010585
Document: 0001950047-26-010585-index.html0001950047-26-010585
Document: 0001950047-26-010585.txt0001950047-26-010585

Track record

40 reports on ORKA

Performance horizon

7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +80.05% at T+60 after the Jun 1, 2026 report. 11 of 11 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $102.46 Now $99.24 −3.14% settles Dec 15
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $104.40 Now $99.24 −4.94% settles Dec 15
  3. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $106.15 Now $99.24 −6.51% settles Dec 15
  4. Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $104.89 Now $99.24 −5.39% settles Dec 15
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  6. Nov 12, 20264d ago 144 Neutral 2/10 Entry $105.35 Now $99.24 −5.80% settles Dec 14
  7. Nov 9, 20267d ago Press Release Neutral 5/10 Entry $109.50 Now $99.24 −9.37% settles Dec 9
  8. Nov 2, 202614d ago Institutional Cluster Neutral 2/10 Entry $99.55 Now $99.24 −0.31% settles Dec 2
  9. Nov 2, 202614d ago 144 Neutral 3/10 Viewing Entry $99.55 Now $99.24 −0.31% settles Dec 2
  10. Oct 26, 202621d ago 8-K Bullish 6/10 Entry $90.33 Now $99.24 +9.86% settles Nov 23
Showing 10 of 40

US Market Status

Market Closed · Opens in 8h 45m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026